Market by Technology, Diagnostic Method, Product, Pathogen, Testing Type, and Country | Forecast 2021-2028
Triton’s report determined
that the Latin American sepsis diagnostics market is predicted to increase at a
CAGR of 7.35% during the anticipated period 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The countries scrutinized in
this market include:
• Brazil
• Mexico
• Rest of Latin America
In Mexico, the prevalence of
maternal sepsis, neonatal sepsis, and other infections increased significantly
over the years. This growth, paired with the rise in healthcare expenditure, is
stimulating the demand for high-end diagnostic equipment and consumables across
the country. Further, the government and non-government organizations are
undertaking several initiatives to prevent and tackle sepsis, specifically in
pediatrics. Therefore, the increase in government support, increasing adoption
of advanced diagnostics techniques, and sepsis prevalence rise are anticipated
to widen the scope and growth of the sepsis diagnostics market in Mexico in the
near future.
Several studies are undertaken
to understand the epidemiology of sepsis in Brazil. This is primarily because
the disease has become a major cause of concern for middle-income countries
like Brazil. Besides, as per these studies, the mortality rate was significantly
higher among the patients in intensive care units in the past few years. The National Institutes of Health (NIH) has established that low availability of resources and adequacy of
treatment were the primary causes of mortality of sepsis patients. This
resulted in healthcare professionals taking multiple efforts to combat sepsis,
stimulating the demand for sepsis diagnosis. Hence, considering these factors,
the Brazilian sepsis diagnostics market is likely to experience growth during
the forecast period.
F Hoffmann-La Roche is a
healthcare company involved in developing and commercializing innovative
therapeutics and diagnostic products. It primarily researches and manufactures
pharmaceutical products in several therapeutic areas, including neuroscience
and infectious diseases. Additionally, the company provides its products to
commercial diagnostic laboratories, hospitals, researchers, and pharmacists. F
Hoffmann has operations across various regions, including Latin America.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. LATIN
AMERICA SEPSIS DIAGNOSTICS MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON SEPSIS DIAGNOSTICS MARKET
2.2. KEY
INSIGHTS
2.3. PORTER’S
FIVE FORCES MODEL
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE PRODUCTS
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. COMPETITIVE
RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
MARKET STRATEGIES
2.6.1. CONTRACTS
AND PARTNERSHIP
2.6.2. BUSINESS
EXPANSION AND DIVESTITURES
2.6.3. ACQUISITIONS
& MERGERS
2.6.4. NEW
PRODUCT LAUNCHES
2.7. MARKET
DRIVERS
2.7.1. RISE
IN HOSPITAL-ACQUIRED INFECTIONS AMONG PATIENTS
2.7.2. INCREASED
PREVALENCE OF SEPSIS
2.8. MARKET
RESTRAINTS
2.8.1. HIGH
COST ASSOCIATED WITH THE INSTRUMENT
2.8.2. REIMBURSEMENT
ISSUES
2.9. MARKET
OPPORTUNITIES
2.9.1. GROWTH
OPPORTUNITIES IN THE EMERGING ECONOMIES
3. LATIN
AMERICA SEPSIS DIAGNOSTICS MARKET - BY TECHNOLOGY
3.1. MICROBIOLOGY
3.2. IMMUNOASSAY
3.3. MOLECULAR
DIAGNOSTICS
3.4. OTHER
TECHNOLOGIES
4. LATIN
AMERICA SEPSIS DIAGNOSTICS MARKET - BY DIAGNOSTIC METHOD
4.1. CONVENTIONAL
DIAGNOSTICS
4.2. AUTOMATED
DIAGNOSTICS
5. LATIN
AMERICA SEPSIS DIAGNOSTICS MARKET - BY PRODUCT
5.1. BLOOD
CULTURE MEDIA
5.2. ASSAY
KITS & REAGENTS
5.3. INSTRUMENTS
6. LATIN
AMERICA SEPSIS DIAGNOSTICS MARKET - BY PATHOGEN
6.1. GRAM
- POSITIVE AND GRAM - NEGATIVE BACTERIAL SEPSIS
6.2. FUNGAL
SEPSIS
6.3. OTHER
PATHOGENS
7. LATIN
AMERICA SEPSIS DIAGNOSTICS MARKET - BY TESTING TYPE
7.1. LABORATORY
TESTING
7.2. POINT-OF-CARE
TESTING
8. LATIN
AMERICA SEPSIS DIAGNOSTICS MARKET – COUNTRY OUTLOOK
8.1. COUNTRY
ANALYSIS
8.1.1. MEXICO
8.1.2. BRAZIL
8.1.3. REST
OF LATIN AMERICA
9. COMPETITIVE
LANDSCAPE
9.1. ABBOTT
LABORATORIES
9.2. BECTON
DICKINSON AND COMPANY (CR BARD)
9.3. BIOMERIEUX
SA
9.4. BRUKER
CORPORATION
9.5. CYTOSORBENTS
9.6. DANAHER
9.7. EKF
DIAGNOSTICS
9.8. F
HOFFMANN-LA ROCHE
9.9. IMMUNEXPRESS
INC
9.10. LUMINEX
CORPORATION
9.11. RESPONSE
BIOMEDICAL CORPORATION
9.12. T2
BIOSYSTEMS INC
9.13. THERMO
FISHER SCIENTIFIC INC
10. RESEARCH
METHODOLOGY & SCOPE
10.1. RESEARCH
SCOPE & DELIVERABLES
10.1.1. OBJECTIVES
OF STUDY
10.1.2. SCOPE
OF STUDY
10.2. SOURCES
OF DATA
10.2.1. PRIMARY
DATA SOURCES
10.2.2. SECONDARY
DATA SOURCES
10.3. RESEARCH
METHODOLOGY
10.3.1. EVALUATION
OF PROPOSED MARKET
10.3.2. IDENTIFICATION
OF DATA SOURCES
10.3.3. ASSESSMENT
OF MARKET DETERMINANTS
10.3.4. DATA
COLLECTION
10.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: LATIN AMERICA SEPSIS DIAGNOSTICS MARKET,
COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: MARKET ATTRACTIVENESS INDEX
TABLE 3: VENDOR SCORECARD
TABLE 4: LIST OF CONTRACTS & PARTNERSHIPS
TABLE 5: LIST OF BUSINESS EXPANSIONS &
DIVESTITURES
TABLE 6: LIST OF ACQUISITIONS & MERGERS
TABLE 7: LIST OF NEW PRODUCT LAUNCHES
TABLE 8: LATIN AMERICA SEPSIS DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 9: LATIN AMERICA SEPSIS DIAGNOSTICS MARKET,
BY DIAGNOSTIC METHOD, 2021-2028 (IN $ MILLION)
TABLE 10: LATIN AMERICA SEPSIS DIAGNOSTICS MARKET, BY
PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 11: LATIN AMERICA SEPSIS DIAGNOSTICS MARKET, BY
PATHOGEN, 2021-2028 (IN $ MILLION)
TABLE 12: GRAM-NEGATIVE BACTERIA CAUSING SEPSIS
TABLE 13: GRAM-POSITIVE BACTERIA CAUSING SEPSIS
TABLE 14: LATIN AMERICA SEPSIS DIAGNOSTICS MARKET, BY
TESTING TYPE, 2021-2028 (IN $ MILLION)
TABLE 15: LATIN AMERICA SEPSIS DIAGNOSTICS MARKET,
COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
FIGURE 1: LATIN AMERICA SEPSIS
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 2: LATIN AMERICA SEPSIS
DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 & 2028 (IN %)
FIGURE 3: LATIN AMERICA SEPSIS
DIAGNOSTICS MARKET, BY MICROBIOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 4: LATIN AMERICA SEPSIS
DIAGNOSTICS MARKET, BY IMMUNOASSAY, 2021-2028 (IN $ MILLION)
FIGURE 5: LATIN AMERICA SEPSIS
DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 6: LATIN AMERICA SEPSIS
DIAGNOSTICS MARKET, BY OTHER TECHNOLOGIES, 2021-2028 (IN $ MILLION)
FIGURE 7: LATIN AMERICA SEPSIS
DIAGNOSTICS MARKET, BY DIAGNOSTIC METHOD, 2020 & 2028 (IN %)
FIGURE 8: LATIN AMERICA SEPSIS
DIAGNOSTICS MARKET, BY CONVENTIONAL DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 9: LATIN AMERICA SEPSIS
DIAGNOSTICS MARKET, BY AUTOMATED DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 10: LATIN AMERICA SEPSIS
DIAGNOSTICS MARKET, BY PRODUCT, 2020 & 2028 (IN %)
FIGURE 11: LATIN AMERICA SEPSIS
DIAGNOSTICS MARKET, BY BLOOD CULTURE MEDIA, 2021-2028 (IN $ MILLION)
FIGURE 12: LATIN AMERICA SEPSIS
DIAGNOSTICS MARKET, BY ASSAY KITS & REAGENTS, 2021-2028 (IN $ MILLION)
FIGURE 13: LATIN AMERICA SEPSIS
DIAGNOSTICS MARKET, BY INSTRUMENTS, 2021-2028 (IN $ MILLION)
FIGURE 14: LATIN AMERICA SEPSIS
DIAGNOSTICS MARKET, BY PATHOGEN, 2020 & 2028 (IN %)
FIGURE 15: LATIN AMERICA SEPSIS
DIAGNOSTICS MARKET, BY GRAM - POSITIVE AND GRAM - NEGATIVE BACTERIAL SEPSIS,
2021-2028 (IN $ MILLION)
FIGURE 16: LATIN AMERICA SEPSIS
DIAGNOSTICS MARKET, BY FUNGAL SEPSIS, 2021-2028 (IN $ MILLION)
FIGURE 17: LATIN AMERICA SEPSIS
DIAGNOSTICS MARKET, BY OTHER PATHOGENS, 2021-2028 (IN $ MILLION)
FIGURE 18: LATIN AMERICA SEPSIS
DIAGNOSTICS MARKET, BY TESTING TYPE, 2020 & 2028 (IN %)
FIGURE 19: LATIN AMERICA SEPSIS
DIAGNOSTICS MARKET, BY LABORATORY TESTING, 2021-2028 (IN $ MILLION)
FIGURE 20: LATIN AMERICA SEPSIS
DIAGNOSTICS MARKET, BY POINT-OF-CARE TESTING, 2021-2028 (IN $ MILLION)
FIGURE 21: LATIN AMERICA SEPSIS
DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
FIGURE 22: MEXICO SEPSIS
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 23: BRAZIL SEPSIS
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 24: REST OF LATIN AMERICA
SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)